BackTable Urology Por arte de portada

BackTable Urology

De: BackTable
Escúchala gratis

  • Resumen

  • The BackTable Urology Podcast is a resource for practicing urologists to learn tips, techniques, and practical advice from their peers in the field. Listen here or on the streaming platform of your choice.
    All rights reserved
    Más Menos
activate_primeday_promo_in_buybox_DT
Episodios
  • Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas

    Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
    Jul 16 2024
    Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros Grivas from Fred Hutchinson Cancer Center and Dr. Sumanta (Monty) Pal from City of Hope. --- CHECK OUT OUR SPONSOR Siemens Healthineers Theranostics https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics --- SYNPOSIS The conversation initially focuses on advanced urothelial carcinoma and the EV302 trial, discussing detailed insights from the quality-of-life results presented at ASCO. The experts offer relevant clinical perspectives for modern metastatic urothelial carcinoma management, focusing on pembrolizumab plus enfortumab vedotin. Further, they delve into breaking biomarker research at ASCO, including KIM-1 in adjuvant renal cell carcinoma (RCC) therapy and the HIF-2 inhibitor DFF332 for chromophobe RCC. --- TIMESTAMPS 00:00 - Introduction 03:42 - Pembrolizumab and Enfortumab Vedotin Trial Insights 07:43 - Future Trials and Treatment Strategies 21:27 - Javelin Bladder 100 Trial Discussion 32:05 - Growth Factor Use 36:21 - Future Directions of Biomarkers 38:55 - Kidney Cancer Biomarker Trials 53:40 - Concluding Thoughts
    Más Menos
    56 m
  • Ep. 177 Latest Approaches to Treat High-Risk NMIBC with Dr. Ashish Kamat

    Ep. 177 Latest Approaches to Treat High-Risk NMIBC with Dr. Ashish Kamat
    Jul 9 2024
    In this episode of the BackTable Urology Podcast, Dr. Ashish Kamat discusses contemporary management of high-risk, non-muscle-invasive bladder cancer (NMIBC) and his thoughts into the future of this arena. --- CHECK OUT OUR SPONSOR Siemens Healthineers Theranostics https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics --- SYNPOSIS Dr. Kamat explores the evolving role of BCG and potential alternative therapies such as gemcitabine and docetaxel. He also covers effective clinical management, emerging clinical trials, and nuanced decision-making principles for radical cystectomy. Finally, the conversation touches on Dr. Kamat’s expert insights regarding the future of NMIBC management, including predictive biomarkers and personalized medicine. --- TIMESTAMPS 00:00 - Introduction 03:56 - Initial Diagnosis and Workup 12:22 - High-Grade Bladder Cancer 22:37 - BCG and Alternative Treatments 31:30 - BCG Unresponsive Disease 36:56 - Novel Intravesical and Systemic Therapies 46:45 - Future Directions --- RESOURCES Related BackTable episodes: https://www.backtable.com/shows/urology/podcasts/64/management-of-bcg-refractory-nmibc https://www.backtable.com/shows/urology/podcasts/157/the-bladder-cancer-matters-podcast https://www.backtable.com/shows/urology/podcasts/103/adjuvant-therapy-for-high-risk-bladder-cancer
    Más Menos
    54 m
  • Ep. 176 Family Planning for Female Urologists: Facts and Figures with Dr. Christine Van Horn and Dr. Charla Holdren

    Ep. 176 Family Planning for Female Urologists: Facts and Figures with Dr. Christine Van Horn and Dr. Charla Holdren
    Jul 2 2024
    Dr. Charla Holdren, a resident at the University of Michigan-West, and Dr. Christine Van Horn, an endourology fellow at Loyola, explore the high rates of infertility and pregnancy complications among female urologists. --- CHECK OUT OUR SPONSOR Fellow https://www.meetfellow.com/ --- SYNPOSIS First, the two experts discuss personal experiences in family planning and challenges faced regularly in the hospital environment. They outline the complexities of assisted reproductive technology and offer insights for a better path forward, including cultural shifts, new policies, and supportive resources to better accommodate the needs of female surgeons. --- TIMESTAMPS 00:00 - Introduction 04:05 - Dr. Holdren and Dr. Van Horn’s Journeys 06:57 - Challenges in Family Planning 17:51 - Parental Leave Policies 26:56 - Advanced Reproductive Technology 33:46 - Looking Towards the Future --- RESOURCES Fellow https://www.meetfellow.com/
    Más Menos
    44 m
Enfermedades Físicas Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre BackTable Urology

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles